Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin

被引：10

作者：

Isoda, Atsushi ^{[1
,2
]}

Miyazawa, Yuri ^{[1
]}

Tahara, Kenichi ^{[1
]}

Mihara, Masahiro ^{[1
]}

Saito, Akio ^{[1
]}

Matsumoto, Morio ^{[1
]}

Sawamura, Morio ^{[1
]}

机构：

[1] Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, Shibukawa, Gunma, Japan

[2] Hoshi Clin, Dept Hematol, Sapporo, Hokkaido, Japan

来源：

INTERNAL MEDICINE | 2020年 / 59卷 / 16期

关键词：

pure red cell aplasia; pembrolizumab; programed cell death 1; immune-related adverse events; direct anti-globulin test; intravenous immunoglobulin; AUTOIMMUNE HEMOLYTIC-ANEMIA; IMMUNOTHERAPY; RITUXIMAB; LYMPHOMA;

D O I：

10.2169/internalmedicine.4467-20

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report a 64-year-old man who was treated with pembrolizumab for relapsed Hodgkin lymphoma. After the third administration of pembrolizumab, he showed acute anemia with a positive direct antiglobulin test. Because of the markedly erythroid hypoplasia, he was diagnosed with pure red cell aplasia (PRCA) caused by pembrolizumab. He was initially treated with prednisolone, but the reticulocytes decreased after tapering prednisolone. He then received high-dose intravenous immunoglobulin (WIG) with prednisolone, and PRCA was successfully treated. Although the pathogenesis of PRCA caused by immune checkpoint inhibitors (CPIs) remains unclear, WIG treatment may be effective for some steroid-refractory CPI-induced PRCA cases.

引用

页码：2041 / 2045

页数：5

共 50 条

[31] Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine
Serra, S
Real, E
Pastor, E
Grau, E
HAEMATOLOGICA, 1999, 84 (12) : 1154 - 1155
[32] Pure red cell aplasia developing after treatment of pleural recurrence of thymoma, successfully treated with cyclosporin A but not with tacrolimus
Fukushima, Kazuhiro
Sato, Toshio
Mitsuhashi, Shigeaki
Gono, Takahisa
Kaneko, Kazuma
Yazaki, Masahide
Mastuda, Masayuki
Ikeda, Shu-ichi
INTERNAL MEDICINE, 2006, 45 (07) : 485 - 486
[33] Drug-induced pure red cell aplasia
Thompson, DF
Gales, MA
PHARMACOTHERAPY, 1996, 16 (06): : 1002 - 1008
[34] Isoniazid Induced Pure Red Blood Cell Aplasia
Azhar, Waqas
Zaidi, Fawwad
Hannan, Abdul
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
[35] Procainamide-induced pure red cell aplasia
Pasha, S. F.
Pruthi, R. K.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 110 (01) : 125 - 126
[36] Emtricitabine-induced pure red cell aplasia
Manickchund, Nithendra
du Plessis, Camille
John, Melanie-Anne A.
Manzini, Thandekile C.
Gosnell, Bemadett, I
Lessells, Richard J.
Moosa, Yunus S.
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2019, 20 (01)
[37] Atezolizumab-induced pure red cell aplasia
Bennett, Rory
Ruskova, Anna
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 10 - 10
[38] Pembrolizumab-induced Myopathy with Anti-striated Muscle Antibodies Successfully Treated by Plasma Exchange
Takahashi, Sunao
Okabayashi, Kotaro
Soejima, Itsuki
Oniki, Ayako
Ishihara, Shoichiro
Tomimitsu, Hiroyuki
INTERNAL MEDICINE, 2023, 62 (23) : 3525 - 3530
[39] Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma
Gargiulo, Luigi
Ibba, Luciano
Valenti, Mario
Costanzo, Antonio
Narcisi, Alessandra
MELANOMA RESEARCH, 2023, 33 (02) : 152 - 154
[40] Niraparib-induced pure red cell aplasia
Yucel, Kadriye Bir
Yildiz, Seyma
Sutcuoglu, Osman
Guvercin, Fatma Sena
Gocun, Pinar Uyar
Ozdemir, Nuriye
Yazici, Ozan
Ozet, Ahmet
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (01) : 210 - 214

← 1 2 3 4 5 →